{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:47:54Z","timestamp":1773326874184,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016126","name":"Beijing Hospitals Authority","doi-asserted-by":"publisher","award":["ZLRK202508"],"award-info":[{"award-number":["ZLRK202508"]}],"id":[{"id":"10.13039\/100016126","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002799","name":"Capital Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002799","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009331","name":"Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012427","name":"Beijing Tiantan Hospital","doi-asserted-by":"publisher","award":["QNJC-2025-03"],"award-info":[{"award-number":["QNJC-2025-03"]}],"id":[{"id":"10.13039\/501100012427","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.nano.2025.102895","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:18:30Z","timestamp":1767745110000},"page":"102895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["In situ vaccination with tumor microenvironment-responsive nanoprodrug for enhanced cancer immunotherapy"],"prefix":"10.1016","volume":"72","author":[{"given":"Dan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiyu","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiping","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.nano.2025.102895_bb0005","first-page":"1384","article-title":"Tumor vaccines: unleashing the power of the immune system to fight cancer","volume":"16","author":"Liu","year":"2023","journal-title":"Pharm"},{"issue":"7","key":"10.1016\/j.nano.2025.102895_bb0010","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1016\/j.apsb.2022.03.002","article-title":"Generation of \u03b1gal-enhanced bifunctional tumor vaccine","volume":"12","author":"He","year":"2022","journal-title":"Acta Pharm Sin B"},{"issue":"29","key":"10.1016\/j.nano.2025.102895_bb0015","doi-asserted-by":"crossref","first-page":"18801","DOI":"10.1021\/acsnano.4c05065","article-title":"Components, formulations, deliveries, and combinations of tumor vaccines","volume":"18","author":"Liu","year":"2024","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.nano.2025.102895_bb0020","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/s41565-024-01753-8","article-title":"Designing nanotheranostics with machine learning","volume":"19","author":"Rao","year":"2024","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"10.1016\/j.nano.2025.102895_bb0025","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41392-023-01674-3","article-title":"Therapeutic cancer vaccines: advancements, challenges and prospects","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"10.1016\/j.nano.2025.102895_bb0030","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.3390\/vaccines10122011","article-title":"Recent advances in cancer vaccines: challenges, achievements, and futuristic prospects","volume":"10","author":"Gupta","year":"2022","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.nano.2025.102895_bb0035","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1021\/accountsmr.4c00362","article-title":"Engineering cellular vesicles for immunotherapy","volume":"6","author":"Lin","year":"2025","journal-title":"Acc Mater Res"},{"key":"10.1016\/j.nano.2025.102895_bb0040","first-page":"107","article-title":"Remodeling tumor immunosuppressive microenvironment via a novel bioactive nanovaccines potentiates the efficacy of cancer immunotherapy","volume":"16","author":"Xie","year":"2022","journal-title":"Bioact Mater"},{"issue":"12","key":"10.1016\/j.nano.2025.102895_bb0045","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.3390\/vaccines9121490","article-title":"Vaccine technologies and platforms for infectious diseases: current progress, challenges, and opportunities","volume":"9","author":"Ghattas","year":"2021","journal-title":"Vaccines"},{"issue":"30","key":"10.1016\/j.nano.2025.102895_bb0050","doi-asserted-by":"crossref","first-page":"26195","DOI":"10.1021\/jacs.5c02774","article-title":"Metal-phenolic outer membrane vesicles for cancer radioimmunotherapy","volume":"147","author":"Zhao","year":"2025","journal-title":"J Am Chem Soc"},{"issue":"5","key":"10.1016\/j.nano.2025.102895_bb0055","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41568-024-00674-x","article-title":"Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity","volume":"24","author":"Meier","year":"2024","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/j.nano.2025.102895_bb0060","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/acs.accounts.3c00771","article-title":"Nanomedicines for an enhanced immunogenic cell death-based in situ cancer vaccination response","volume":"57","author":"Zhao","year":"2024","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.nano.2025.102895_bb0065","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.actbio.2025.01.029","article-title":"Manganese dioxide-based in situ vaccine boosts antitumor immunity via simultaneous activation of immunogenic cell death and the STING pathway","volume":"194","author":"Peng","year":"2025","journal-title":"Acta Biomater"},{"issue":"5","key":"10.1016\/j.nano.2025.102895_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189154","article-title":"Reactive oxygen species of tumor microenvironment: harnessing for immunogenic cell death","volume":"1879","author":"Malla","year":"2024","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"6","key":"10.1016\/j.nano.2025.102895_bb0075","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1039\/D5MD00039D","article-title":"Investigation of the in vitro anticancer potential of bis (imino) acenaphthene-N-heterocyclic carbene transition metal complexes revealed TrxR inhibition and triggering of immunogenic cell death (ICD) for allyl palladates","volume":"16","author":"Donati","year":"2025","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.nano.2025.102895_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124045","article-title":"Nanoparticle-mediated immunogenic cell death for cancer immunotherapy","volume":"656","author":"Qi","year":"2024","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.nano.2025.102895_bb0085","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3390\/ijms26041613","article-title":"Immunogenic cell death inducers in cancer immunotherapy to turn cold tumors into hot tumors","volume":"26","author":"Lucarini","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2025.102895_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123094","article-title":"A mitochondria-interfering nanocomplex cooperates with photodynamic therapy to boost antitumor immunity","volume":"317","author":"Zhang","year":"2025","journal-title":"Biomater"},{"issue":"13","key":"10.1016\/j.nano.2025.102895_bb0095","article-title":"A PD-L1 siRNA-loaded boron nanoparticle for targeted cancer radiotherapy and immunotherapy","volume":"37","author":"Deng","year":"2025","journal-title":"Adv Biomater"},{"issue":"6","key":"10.1016\/j.nano.2025.102895_bb0100","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","article-title":"Targeting immunogenic cell stress and death for cancer therapy","volume":"23","author":"Galluzzi","year":"2024","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.nano.2025.102895_bb0105","doi-asserted-by":"crossref","first-page":"434","DOI":"10.7150\/thno.67300","article-title":"Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy","volume":"12","author":"Ji","year":"2022","journal-title":"Theranostics"},{"issue":"22","key":"10.1016\/j.nano.2025.102895_bb0110","doi-asserted-by":"crossref","first-page":"2201734","DOI":"10.1002\/advs.202201734","article-title":"Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency","volume":"9","author":"Li","year":"2022","journal-title":"Adv Sci"},{"issue":"3","key":"10.1016\/j.nano.2025.102895_bb0115","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.7150\/thno.86004","article-title":"In situ vaccination caused by diverse irradiation-driven cell death programs","volume":"14","author":"Wang","year":"2024","journal-title":"Theranostics"},{"issue":"43","key":"10.1016\/j.nano.2025.102895_bb0120","doi-asserted-by":"crossref","first-page":"29439","DOI":"10.1021\/acsnano.3c12337","article-title":"Robust and sustained STING pathway activation via hydrogel-based in situ vaccination for cancer immunotherapy","volume":"18","author":"Cheng","year":"2024","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.nano.2025.102895_bb0125","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1038\/s41467-022-35130-7","article-title":"Engineered lactococcus lactis secreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapy","volume":"13","author":"Zhu","year":"2022","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.nano.2025.102895_bb0130","first-page":"428","article-title":"Adjuvant drug-assisted bone healing: advances and challenges in drug delivery approaches","volume":"12","author":"Rothe","year":"2020","journal-title":"Pharm"},{"issue":"3","key":"10.1016\/j.nano.2025.102895_bb0135","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41563-020-0793-6","article-title":"A DNA nanodevice-based vaccine for cancer immunotherapy","volume":"20","author":"Liu","year":"2021","journal-title":"Nat Mater"},{"key":"10.1016\/j.nano.2025.102895_bb0140","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ijbiomac.2021.12.129","article-title":"Recent advances on chitosan as an adjuvant for vaccine delivery","volume":"200","author":"Dmour","year":"2022","journal-title":"Int J Biol Macromol"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963425000966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963425000966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:04:49Z","timestamp":1773277489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963425000966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":28,"alternative-id":["S1549963425000966"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2025.102895","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In situ vaccination with tumor microenvironment-responsive nanoprodrug for enhanced cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2025.102895","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102895"}}